ZYL certainly have taken an aggressive stance on this, so you would have to think it's not without reason.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025